Episode Details
Back to Episodes
mRNA Adjuvant Boosts Immunity, Colossal Biosciences Sparks Skepticism Over Egg Tech, Pediatric Dexmedetomidine Boosts Cognition, FSU Breakthrough Synthesizes Marine Compounds, and more...
Published 1 week, 5 days ago
Description
(0:10): Breakthrough mRNA Adjuvant Boosts T-Cell Responses, Shows Promise for Cancer Immunotherapy and Infectious Disease Vaccines
(2:36): Colossal Biosciences' Moa Revival: Artificial Egg Technology Sparks Skepticism Despite Engineering Feats
(4:29): Study Reveals Pediatric Sedation with Dexmedetomidine Linked to Better Long-Term Cognitive Outcomes
(6:34): FSU Achieves Breakthrough in Synthesizing Marine Compounds for Cancer Drug Development
(9:00): Glycan Atlasing Offers Breakthrough in Early Disease Detection and Diagnosis Through Sugar Mapping
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Time
(2:36): Colossal Biosciences' Moa Revival: Artificial Egg Technology Sparks Skepticism Despite Engineering Feats
(4:29): Study Reveals Pediatric Sedation with Dexmedetomidine Linked to Better Long-Term Cognitive Outcomes
(6:34): FSU Achieves Breakthrough in Synthesizing Marine Compounds for Cancer Drug Development
(9:00): Glycan Atlasing Offers Breakthrough in Early Disease Detection and Diagnosis Through Sugar Mapping
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Time